Amyris (AMRS) IPO Jumps Higher
Tweet Send to a FriendGet Alerts AMRS Hot Sheet
Up)
Trade AMRS Now!
The IPO for Amyris (Nasdaq: AMRS) is open for trading. Shares are trading at $17.03 after pricing 5.3 million shares for $16.
Underwriters for the offering were Morgan Stanley, Goldman Sachs and JPMorgan.
Amyris is building an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Underwriters for the offering were Morgan Stanley, Goldman Sachs and JPMorgan.
Amyris is building an integrated renewable products company applying industrial synthetic biology to genetically modify microorganisms to serve as living factories.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- UPDATE: Cubist Pharmaceuticals (CBST) Spikes to Session Highs
- UPDATE: Cell Therapeutics (CTIC) on The Move
Create E-mail Alert Related Categories
Hot List, IPOs, Trader TalkRelated Entities
JPMorgan, Morgan Stanley
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
